# Privia Health Group Inc. (PRVA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Providers & Services. Price $20.66, market value $2.6 billion.

## Valuation
- **P/E (trailing): 93.9×** (5-yr avg 143.6×, 3-yr avg 143.6×). Privia Health Group Inc. trades at 93.9× trailing earnings, well below its own five-year average of 143.6×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 19.4×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.31**. A PEG of 0.31 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.1×**. Each dollar of revenue is priced at 1.1×.
- **Price / book: 3.3×**. The shares trade at 3.3× book value; book value is a meaningful part of the valuation.
- **Earnings yield: 1.1%**. The inverse of the P/E: 1.1% of the price is earned each year.

## Profitability
- **Operating margin: 1.9%**. 1.9% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 1.1%**. 1.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 3.1%**. 3.1% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 2.1%**. Each dollar of assets produces 2.1% of profit.

## Growth
- **Revenue growth (1 yr): 22.3%** (3-yr 16.1%/yr, 5-yr 21.0%/yr). Revenue grew 22.3% over the last year, against 21.0% a year compounded over five years.
- **EPS growth (1 yr): 63.6%** (5-yr -11.4%/yr). Earnings per share rose 63.6%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 1.60** (quick 1.60). Current assets cover the next year's liabilities 1.60 times.
- **Altman Z-score: 5.42**. A Z-score of 5.42 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Privia Health Group Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (18 analysts). 18 analysts cover Privia Health Group Inc.; the consensus is strong_buy, with an average price target of $31.67 (+53% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -10.6%** (YTD -12.9%, 3-mo -4.5%). The shares are down 10.6% over twelve months including dividends.
- **From 52-week high: -28.3%** (5.8% above the low). Trading 28% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 29**. An RSI of 29 is oversold; bounces are common, but oversold can stay oversold in a real decline.
- **Beta (1 yr): 0.66** (volatility 32%). Beta of 0.66 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PRVA · Page: https://foliofundamentals.com/stocks/prva

Not investment advice.